Global Market Study on Proteomics: Increasing Application in Molecular Disease Diagnosis & Drug Discovery Boosting Demand

Proteomics  Market
  • Published On : Apr-2020 |
  • Pages : 245 Pages |
  • Format : Proteomics  Market Proteomics  Market Proteomics  Market Proteomics  Market

Proteomics is a rapidly evolving field in disease diagnosis. Proteomics are used to identify proteins involved in a disease and study their expression, function, and structure. Proteomic studies are also used to identify prognostic markers, and offer diagnostics for cancer, infectious diseases, malaria, and tuberculosis. Proteomics are used in the drug industry to investigate the mechanism of drug action or toxicity. They are also being used widely for the identification and validation of the efficacy of biomarkers.

Proteomics play a significant role in drug development, and therefore, many drug manufacturers have started their own proteomic divisions, which is boosting the growth of the global proteomics market, expected to surge at a high CAGR of 17% from 2019 to 2029.

Increasing Demand for Personalized Medicine Surging Proteomics Market

Advances in proteomic research have made important contributions to the development of personalized medicine by expediting the detection of protein biomarkers, protein biochips & pharmacoproteomics, and proteomics-based molecular diagnostics. Personalized medicines are a promising approach and effective treatment against cancer, neurodegenerative diseases, and rare genetic conditions.

In cancer, personalized medicine is prescribed according to genetic modification, and also provides information about a person’s tumor profiling and plan treatment. The progress of proteomics in achieving personalized therapy has been possible due to tremendous advancements in protein interactions, protein expression patterns, modifications, and translation techniques.

Demand in East Asia and South Asia on Upswing

North America and Europe currently hold more than 55% of the global proteomics market. The high prevalence of genetic diseases such as cancer and infectious diseases such as malaria and tuberculosis are propelling the demand for proteomic products and services in North America.

However, East Asia and South Asia are poised for significant growth in the global proteomics market over the forecast period, owing to factors such as large population base, increased burden of cancer & infectious diseases, and wide use of proteomics in genetic disease diagnosis. Increased R&D investments and government initiatives are expected to boost the demand for proteomic-based disease diagnosis in these regions.

COVID-19 Pandemic Altering Drug Manufacturing Scenario

The global pandemic is expected to have a measurable impact on the rapid growth of the proteomic market. Pharmaceutical companies, which have been significant end users of the proteomics market, are limiting the manufacturing of drugs due to the shortage of raw materials. Active pharmaceutical players are shifting toward the manufacturing of essential medicines that are of utmost need at the moment. Owing to this fact, the proteomics market is expected to take a backseat in the priorities of manufacturers for now.

On a positive note, numerous proteomic labs are exploring therapeutic options, and these studies have yielded potential drug targets, some of which are now being tested, and are finding information that could potentially aid the development of more rapid diagnostics for the virus. This is expected to alleviate the loss that the pandemic is expected to cause, to some extent.

Analysts’ Viewpoint

An extensive analysis of the proteomics market has brought our analysts to a conclusion that, the market is growing at a significant pace. Currently, reagents & kits is the target segment for major players operating in the proteomics market. Hence this segment dominates the global proteomics market by component, in term of market growth. Europe and North America collectively hold more than 55% of revenue share due to the high adoption of proteomic components in these regions. Emerging countries such as Brazil, South Africa, and Argentina are expected to offer lucrative opportunities for players in the proteomics market in the coming years, owing to increasing awareness and initiatives by local governments for research & development in protein engineering.

Proteomics Market - Scope of the Report

The latest publication by Persistence Market Research (PMR) on the global proteomics market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global proteomics market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities in the Proteomics market. The principal aim of the market study is to present exclusive information about how the market will perform in the forecast period of 2019-2029.

Important indicators for the successful growth of the Proteomics market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR) are described in an exhaustive way in PMR's research. This research study can support readers to know the demand for Proteomics quantitative development opportunities during the study period.

The research is beneficial for shareholders in proteomics, including proteomics market investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the proteomics market. The insights and wisdom presented in this PMR study can be leveraged by shareholders in the proteomics market, industry experts, investors, researchers, reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as microeconomic variables affecting the business scenario in the proteomics market are also included in the current study. Depending on potential developments in the proteomics market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this proteomics market report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the proteomics market.

Key Segments of Proteomics Market

PMR’s study on the proteomics market offers information divided into five important segments— component, technology, application, end user, and region. This report offers comprehensive data and information about important market dynamics and growth parameters associated with these categories.



  • Instruments
    • Spectrometry
    • Protein Microarray Systems
    • Chromatography Systems
    • Surface Plasmon Resonance
    • Electrophoresis
    • Protein Fractionation Systems
    • X-ray Crystallography
  • Reagents and Kits
    • Protein Microarray Reagents
    •  X-Ray Crystallography Reagents
    • Spectroscopy Reagents
    • Chromatography Reagents
    • Electrophoresis Reagents
    • Protein Fractionation Reagents
  • Core Proteomics Services
    • Protein Identification Services
    • Protein Separation Services
  • Microarrays
  • X-Ray Crystallography
  • Spectroscopy
  • Chromatography
  • Protein Fractionation Systems
  • Electrophoresis
  • Surface Plasma Resonance Systems


  • Drug Discovery
  • Clinical Diagnosis
  • Cancer Research

End User


  • Contract Research Organizations (CROs)
  • Research & Academic Institutions
  • Pharma & Biotech Companies   
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Key Questions Answered in PMR’s Proteomics Market Report

  • Which regions will continue to remain the most profitable regional markets for proteomics market players?
  • Which factors will induce a change in the demand for proteomics during the assessment period?
  • How will changing trends impact the proteomics market?
  • How can market players capture the low-hanging opportunities in the proteomics market in developed regions?
  • What are the winning strategies of stakeholders in the proteomics market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might have to tackle while investing in the proteomics market?
  • What are the developmental trends in proteomics that will impact the market?
  • How can businesses in the proteomics market avail the growth opportunities in developed and emerging sectors?

Proteomics Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the proteomics market, and reach conclusions on future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the proteomics market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the proteomics market, and makes PMR’s projection on the growth prospects of a proteomics market more accurate and reliable.

Companies covered in Proteomics Market Report

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc. (US)
  • GE Healthcare (US)
  • Danaher Corporation (US)
  • PerkinElmer, Inc. (US)
  • Merck KGaA (Germany)
  • Caprion Proteomics Inc.
  • Bio-Rad Laboratories
  • Luminex Corporation (US)
  • Waters Corporation
  • Promega Corporation
  • Bruker Corporation
Back To Top